dc.contributor.author | Gómez-Almaguer, D. | |
dc.contributor.author | Vázquez-Mellado, A. | |
dc.contributor.author | Navarro-Cabrera, J.R. | |
dc.contributor.author | Abello-Polo, V. | |
dc.contributor.author | Milovic, V. | |
dc.contributor.author | García, J. | |
dc.contributor.author | Basquiera, A.L. | |
dc.contributor.author | Saba, S. | |
dc.contributor.author | Vela-Ojeda, J. | |
dc.contributor.author | Gómez, S. | |
dc.contributor.author | Karduss-Aurueta, A. | |
dc.contributor.author | Bustinza-Álvarez, A. | |
dc.contributor.author | Requejo, A. | |
dc.contributor.author | Feldman, L. | |
dc.contributor.author | Jaime-Pérez, J.C. | |
dc.contributor.author | Yantorno, S. | |
dc.contributor.author | Kusminsky, G. | |
dc.contributor.author | Gutiérrez-Aguirre, CH | |
dc.contributor.author | Arbelbide, J. | |
dc.contributor.author | Martinez-Rolon, J. | |
dc.contributor.author | Jarchum, G. | |
dc.contributor.author | Jaimovich, G. | |
dc.contributor.author | Riera, L. | |
dc.contributor.author | Pedraza-Mesa, E. | |
dc.contributor.author | Villamizar-Gómez, L. | |
dc.contributor.author | Herrera-Rojas, M.A. | |
dc.contributor.author | Gamboa-Alonso, M.M. | |
dc.contributor.author | Foncuberta, C. | |
dc.contributor.author | Rodríguez-González, G. | |
dc.contributor.author | García Ruiz-Esparza, M.A. | |
dc.contributor.author | Hernández-Maldonado, E. | |
dc.contributor.author | Paz-Infanzón, M. | |
dc.contributor.author | González-López, E. | |
dc.contributor.author | Ruiz-Argüelles, G.J. | |
dc.date.accessioned | 2019-04-08T14:46:57Z | |
dc.date.available | 2019-04-08T14:46:57Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Bone Marrow Transplant | es_PE |
dc.identifier.issn | 0268-3369 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12959/141 | |
dc.description.abstract | Se estudió los casos de 298 pacientes con anemia aplásica severa aloinjertados, en cuatro países de América Latina: Argentina, México, Perú y Colombia. Se proporciona datos reales del impacto de la administración de fuente de células madre y de globulina antitimocito en el trasplante de hermanos con idéntico Antígeno leucocitario humano. | es_PE |
dc.format | application/pdf | es_PE |
dc.language.iso | eng | es_PE |
dc.publisher | Seguro Social de Salud (EsSalud) | es_PE |
dc.rights | info:eu-repo/semantics/openAccess | es_PE |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | es_PE |
dc.source | Seguro Social de Salud (EsSalud) | es_PE |
dc.source | Repositorio Institucional EsSalud | es_PE |
dc.subject | Hematología | es_PE |
dc.subject | Anemia Aplásica | es_PE |
dc.title | The Latin American experience of allografting patients with severe aplastic anaemia: Real-world data on the impact of stem cell source and ATG administration in HLA-identical sibling transplants. | es_PE |
dc.type | info:eu-repo/semantics/article | es_PE |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.05.00 | es_PE |
dc.publisher.country | PE | es_PE |